ClinicalTrials.Veeva

Menu

Effects of Dexmedetomidine on Postoperative Cognitive Dysfunction During One-lung Ventilation in Elder Patients

T

Tang-Du Hospital

Status and phase

Unknown
Phase 4

Conditions

Postoperative Confusion

Treatments

Drug: Normal saline
Drug: Induction of anesthesia,midazolam ,sufentanil,etomidate and rocuronium
Drug: Maintenance of anesthesia , propofol, remifentanil,vecuronium
Drug: Dexmedetomidine

Study type

Interventional

Funder types

Other

Identifiers

NCT02134093
Tangdu sedation

Details and patient eligibility

About

This study is to explore the effects of dexmedetomidine on postoperative cognitive dysfunction during one-lung ventilation in elder patients.

Enrollment

120 estimated patients

Sex

All

Ages

55 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Written informed consent.
  • Ongoing one-lung ventilation surgery.
  • American Society of Anesthesiologists class I to III.
  • Aged between 55 and 75 years old.
  • Body Mass Index between 18 and 25 kg/m2.

Exclusion criteria

  • Systolic blood pressure more than 180 mmHg or lower than 90 mmHg,diastolic blood pressure more than 110 mmHg or lower than 60 mmHg.
  • Serious heart,liver,kidney, pulmonary, and endocrine disease or serious infection.
  • Suspected or confirmed difficult airway.
  • History of abnormal anesthesia.
  • Suspected of malignant hyperthermia.
  • Use of sedative and antidepressant drug or serious alcoholism
  • Mini-mental State Examination less than 17.
  • Highest academic degree below grade 6 in primary schools
  • Patients inability to exchange with serious visual and hearing impairment or mental disability.
  • History of shock.
  • Carotid artery stenosis and central nervous system disease such as stroke, epilepsy.
  • Allergic to investigational products or with other contraindication.
  • Participated in other study within 30 days .

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

120 participants in 3 patient groups, including a placebo group

Normal saline
Placebo Comparator group
Description:
Continuous pump infusion of normal saline with identical volume, compared with the low dose and high dose group,until the end of surgery
Treatment:
Drug: Maintenance of anesthesia , propofol, remifentanil,vecuronium
Drug: Normal saline
Drug: Induction of anesthesia,midazolam ,sufentanil,etomidate and rocuronium
High dose group, dexmedetomidine
Experimental group
Description:
Continuous pump infusion dexmedetomidine at 1μg/kg for 15 minutes before anesthesia induction ,then continuous pump infusion dexmedetomidine at 0.4μg/kg/h until the end of surgery
Treatment:
Drug: Maintenance of anesthesia , propofol, remifentanil,vecuronium
Drug: Induction of anesthesia,midazolam ,sufentanil,etomidate and rocuronium
Drug: Dexmedetomidine
Low dose group, dexmedetomidine
Experimental group
Description:
Continuous pump infusion dexmedetomidine at 0.5μg/kg for 15 minutes before anesthesia induction ,then continuous pump infusion dexmedetomidine at 0.2μg/kg/h until the end of surgery
Treatment:
Drug: Maintenance of anesthesia , propofol, remifentanil,vecuronium
Drug: Induction of anesthesia,midazolam ,sufentanil,etomidate and rocuronium
Drug: Dexmedetomidine

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems